FGEN - FibroGen Quarterly EPS earnings growth
FibroGen, Inc. (FGEN) generates revenue from the sale of treatments for anemia and tissue diseases. The relative growth of quarterly EPS illustrates the market response to these results, where the 959.30 metric indicates the status of the current trend. Partnerships with global pharma behemoths are accelerating growth, while management is currently optimizing expenses to restore shareholder confidence following past failures.
%20Earnings%20per%20share%20growth%20in%20annualized%20terms%20for%20the%20last%20twelve%20months&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_FGEN_-_FibroGen-Inc._-_Earnings-per-share-growth-in-annualized-terms-for-the-last-twelve-months "fibrogen.com (FGEN): Year-over-year earnings per share growth for the last twelve months from 07/04/2022 to 01/08/2026 | 👁️GURU.Markets👁️")
Summary analytical data breakdowns for FibroGen Corporation (FGEN)
- share price and expert price forecast:
- market capitalization statistics:
- balance sheet net asset value indicators:
- company liabilities and liquidity data:
Total Debt to Capital FibroGen, Inc.|FGEN - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital FibroGen, Inc.|FGEN - Company Debts|Debt to Book Capitalization Ratio FibroGen Corp|FGEN - Company Long-Term Loans and Borrowings|Company Short-Term Debt FibroGen|Quick Ratio fibrogen.com
- earnings and market multiples details:
FGEN - Annual Net Income|Projected Future Earnings FibroGen, Inc.|FGEN - Market Cap to Earnings|Future Price to Earnings FibroGen Corp|FGEN - Growth-Adjusted P/E Ratio|Enterprise Value to EBITDA Ratio FibroGen Corp|FGEN - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) FibroGen|FGEN - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months fibrogen.com|FGEN - Earnings per share growth this year|Earnings growth forecast for next year FibroGen, Inc.
Fundamental valuation:FibroGen, Inc.
The development of cancer and anemia drugs in partnership with AstraZeneca and Astellas makes FibroGen, Inc. (FGEN) dependent on the effectiveness of commercializing joint discoveries. Earnings per share dynamics measure the growth rate of net income, allowing investors to detect a slowdown in business development before a crisis occurs by analyzing quarterly EPS growth levels to protect capital from deep drawdowns.
Who FibroGen, Inc. competes with
HLN: Quarterly EPS earnings growth|Kenvue Inc - Year-over-year earnings per one share growth for the last 12 months|VRNA (Verona Pharma Corp) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Jyong Bio MENS|Year-over-year earnings per share growth for the last twelve months Ligand Pharmaceuticals (LGND)|AMRX (amneal.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth PRGO (Perrigo)|ALVO (Alvotech S.A.) - Year-over-year net earnings per share trend for the last twelve months|Liquidia Technologies - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Galapagos Corp GLPG|ANIP: Quarterly EPS earnings growth|MNKD (mannkindcorp.com) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last twelve months Amphastar Pharmaceuticals, Inc.|PCRX: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months ARS Pharma (SPRY)|TBPH - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth AQST (Aquestive Therapeutics)|Net earnings per share growth for the trailing year scPharmaceuticals, Inc.|Tectonic - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Tonix Pharma|sxtchina.com (SXTC) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months EPRX|Year-over-year net earnings per share growth for the last 12 months BHST|EXOZ: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ORMP|Year-over-year net earnings per share change for the last twelve months enterabio.com|Year-over-year earnings per share growth for the last twelve months MindWalk HYFT|ABVC: Year-over-year earnings per share growth for the last 12 months|Cumberland Pharmaceuticals - Quarterly EPS earnings growth|quantumbiopharma.com (QNTM) - Year-over-year net earnings per share growth for the last 12 months|TELO (Telomir Pharmaceuticals, Inc.) - Year-over-year net earnings per share growth for the last 12 months|RANI - Year-over-year net earnings per share change for the last twelve months|SNYR (Synergy CHC Corp.) - Quarterly EPS earnings growth|Rallybio Corp. - Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth LEXX|pulmatrix.com (PULM) - Net earnings per share growth for the trailing year|Quarterly EPS earnings growth PTHL (Pheton Holdings)|Aptorum Group Ltd (APM) - Earnings per share growth in annualized terms for the last twelve months|LYRA - Year-over-year earnings per share growth for the last twelve months|IBO (impactbiomedinc.com) - Year-over-year earnings per share growth for the last 12 months|tnfpharma.com (TNFA) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months YCBD (cbdMD)|PRFX (PainReform) - Quarterly EPS earnings growth|CYTO: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth LIPO|Quarterly EPS earnings growth OptiNose Corp (OPTN)|Year-over-year earnings per share growth for the last twelve months Pieris Pharmaceuticals PIRS|Year-over-year earnings per one share growth for the last 12 months PROC|PTPI - Year-over-year earnings per share growth for the last twelve months|Qilian International Holding Group (QLI) - Year-over-year net earnings per share growth for the last 12 months|SLRN: Quarterly EPS earnings growth|TFF Pharmaceuticals, Inc (TFFP) - Quarterly EPS earnings growth
